Randomized, Double-Blind, Phase III Trial of Chemotherapy Plus the Transcriptional Therapy Hydralazine and Magnesium Valproate Versus Chemotherapy Plus Placebo in Recurrent and Metastatic Cervical Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hydralazine (Primary) ; Magnesium valproate (Primary) ; Cisplatin; Topotecan
- Indications Cervical cancer
- Focus Therapeutic Use
- 18 Nov 2009 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 30 Mar 2009 Biomarkers information updated
- 06 Oct 2007 New trial record.